Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504580 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Maria João Sousa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pôle De Recherche en Physiopathologie de La Reproduction, Instituite of Experimental and Clinique Research, Université Catholique De Louvain, Brussel…. Hauptthemen laut MEDLINE: Bioengineering, Ovarian Follicle, Hormone Replacement Therapy, Ovary. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation Louvain.
Abstract (Originalsprache)
Premature ovarian insufficiency (POI) is a complex endocrine disorder characterized by the loss of ovarian function before age 40, leading to infertility, hypoestrogenism, and systemic complications. Conventional hormone replacement therapies (HRTs) offer only partial relief, failing to replicate the dynamic feedback of endogenous hormone regulation. Advances in tissue engineering, stem cell technology, and microphysiological systems have catalyzed the development of bioengineered platforms that mimic native ovarian endocrine function. This review outlines progress from three‐dimensional (3D) follicle‐mimetic constructs and scaffold‐free organoids to dynamic ovary‐on‐a‐chip systems, emphasizing advances in steroidogenesis reconstitution, innovations in granulosa‐theca co‐cultures, and the design of cell‐based hormone replacement therapies (cHRTs) capable of re‐engaging the hypothalamic‐pituitary‐ovarian (HPO) axis. We also address critical translational challenges including immunoisolation, vascularization, and regulatory pathway. By bridging bioengineering and reproductive medicine, cHRTs represent a paradigm shift, offering the potential to restore endocrine health, fertility, and systemic homeostasis in a personalized and physiologically relevant manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pôle De Recherche en Physiopathologie de La Reproduction, Instituite of Experimental and Clinique Research, Université Catholique De Louvain, Brussels, Belgium.
ORCID-Profile: Christiani A Amorim
Förderung
- Foundation Louvain
Zitieren
APA
Sousa, M. J., & Amorim, C. A. (2026). Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504580
Vancouver
Sousa MJ, Amorim CA. Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504580
BibTeX
@article{Sousa2026,
author = {Sousa, Maria João and Amorim, Christiani A},
title = {Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504580}
}
EUVIMED